Humana Inc (NYSE:HUM) – Equities researchers at Jefferies Financial Group increased their Q3 2018 EPS estimates for Humana in a research note issued on Wednesday, August 1st, according to Zacks Investment Research. Jefferies Financial Group analyst D. Windley now anticipates that the insurance provider will earn $4.42 per share for the quarter, up from their previous forecast of $4.12. Jefferies Financial Group currently has a “Buy” rating and a $372.00 target price on the stock. Jefferies Financial Group also issued estimates for Humana’s Q4 2018 earnings at $2.51 EPS, FY2018 earnings at $14.25 EPS and FY2019 earnings at $17.45 EPS.
Other analysts have also recently issued reports about the company. Zacks Investment Research cut Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, August 8th. Citigroup restated a “buy” rating and issued a $340.00 price objective (up from $280.00) on shares of Humana in a research report on Friday, June 1st. Argus boosted their price objective on Humana from $270.00 to $330.00 and gave the company a “buy” rating in a research report on Monday, April 16th. Oppenheimer boosted their price objective on Humana from $305.00 to $311.00 and gave the company an “outperform” rating in a research report on Thursday, May 3rd. Finally, Royal Bank of Canada restated a “hold” rating and issued a $318.00 price objective on shares of Humana in a research report on Thursday, August 2nd. Seven research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $318.17.
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, August 1st. The insurance provider reported $3.96 earnings per share for the quarter, beating the consensus estimate of $3.79 by $0.17. The company had revenue of $14.26 billion during the quarter, compared to analysts’ expectations of $14.16 billion. Humana had a return on equity of 17.43% and a net margin of 2.48%. During the same period last year, the business earned $3.49 earnings per share.
In other Humana news, SVP Cynthia H. Zipperle sold 1,000 shares of the business’s stock in a transaction on Wednesday, June 13th. The stock was sold at an average price of $306.01, for a total transaction of $306,010.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Elizabeth D. Bierbower sold 6,036 shares of the business’s stock in a transaction on Monday, June 11th. The stock was sold at an average price of $300.91, for a total value of $1,816,292.76. Following the transaction, the insider now directly owns 21,683 shares in the company, valued at approximately $6,524,631.53. The disclosure for this sale can be found here. Insiders have sold 104,976 shares of company stock worth $32,165,337 in the last three months. 0.60% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Raymond James Trust N.A. boosted its stake in Humana by 19.8% during the second quarter. Raymond James Trust N.A. now owns 956 shares of the insurance provider’s stock worth $284,000 after buying an additional 158 shares during the last quarter. Trust Co boosted its stake in Humana by 7.7% during the first quarter. Trust Co now owns 2,326 shares of the insurance provider’s stock worth $625,000 after buying an additional 167 shares during the last quarter. Daiwa SB Investments Ltd. boosted its stake in Humana by 27.9% during the second quarter. Daiwa SB Investments Ltd. now owns 780 shares of the insurance provider’s stock worth $232,000 after buying an additional 170 shares during the last quarter. Advisor Partners LLC lifted its stake in shares of Humana by 5.3% in the 2nd quarter. Advisor Partners LLC now owns 3,604 shares of the insurance provider’s stock valued at $1,073,000 after purchasing an additional 180 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. lifted its stake in shares of Humana by 1.7% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 11,901 shares of the insurance provider’s stock valued at $3,541,000 after purchasing an additional 197 shares during the last quarter. 93.40% of the stock is currently owned by institutional investors.
Humana Company Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
Featured Article: Find a Trading Strategy That Works
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.